Beta-blocker decreases the increase in QT dispersion and transmural dispersion of repolarization induced by bepridil

Circulation Journal

Volumn 66, Issue 11, 2002, Pages 1024-1028

  Yoshiga, Yasuhiro ^a   Shimizu, Akihiko ^a   Yamagata, Toshihiko ^a   Hayano, Tomoko ^a   Ueyama, Takeshi ^a   Ohmura, Masato ^a   Itagaki, Kazuo ^a   Kimura, Masayasu ^a   Matsuzaki, Masunori ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

blocker; QT dispersion; QT interval; Repolarization; Transmural dispersion

Indexed keywords

AMIODARONE; BEPRIDIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; METOPROLOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HEART ATRIUM FIBRILLATION; HEART REPOLARIZATION; HUMAN; LONG QT SYNDROME; MALE; QT INTERVAL; SIDE EFFECT; TORSADE DES POINTES;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; BEPRIDIL; BISOPROLOL; DRUG ANTAGONISM; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; LONG QT SYNDROME; MALE; METOPROLOL; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0242684752     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.66.1024     Document Type: Article

References (27)

1. Julian DG, Camm AJ, Frangin G, Jans MJ, Munoz A, Schwartz PJ, et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Lancet 1997; 349: 667-674.
2. Burkart F, Pfisterer M, Kiowski W, Follath F, Burckhardt D. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel antiarrhythmic study of infarct survival. J Am Coll Cardiol 1990; 16: 1711-1718.
3. Cairns JA, Connolly SJ, Roberts R, Gent M. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet 1997; 349: 675-682.
4. Navarro-Lopez F, Cosin J, Marrugat J, Guindo J, Bayes de Luna A. Comparison of the effects of amiodarone versus metoprolol on the frequency of ventricular arrhythmias and on mortality after acute myocardial infarction. SSSD Investigators. Spanish Study on Sudden Death. Am J Cardiol 1993; 72: 1243-1248.
5. Chun SH, Sager PT, Stevenson WG, Nademanee K, Middlekauff HR, Singh BN. Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter. Am J Cardiol 1995; 76: 47-50.
6. Kerin NZ, Faitel K, Kerin IA, Quinones L, Stomel RJ. Efficacy of low-dose amiodarone in the prevention of paroxysmal atrial fibrillation resistant to type IA antiarrhythmic drugs. Am J Ther 2000; 7: 245-250.
7. Prystowsky EN. Effects of bepridil on cardiac electrophysiologic properties. Am J Cardiol 1992; 69: 63D-67D.
8. Coumel P. Safety of bepridil: From review of the European data. Am J Cardiol 1992; 69: 75D-78D.
9. Singh BN. Bepridil therapy: Guidelines for patient selection and monitoring of therapy. Am J Cardiol 1992; 69: 79D-85D.
10. Linker NJ, Colonna P, Kekwick CA, Till J, Camm AJ, Ward DE. Assessment of QT dispersion in symptomatic patients with congenital long QT syndromes. Am J Cardiol 1992; 69: 634-638.
11. Shimizu W, Antzelevitch C. Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: Effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes. Circulation 1998; 98: 2314-2322.
12. Shimizu W, Antzelevitch C. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome. Circulation 1997; 96: 2038-2047.
13. Shimizu W, Kurita T, Matsuo K, Suyama K, Aihara N, Kamakura S, et al. Improvement of repolarization abnormalities by a K+ channel opener in the LQT1 form of congenital long-QT syndrome. Circulation 1998; 97: 1581-1588.
14. Hii JT, Wyse DG, Gillis AM, Duff HJ, Solylo MA, Mitchell LB. Precordial QT interval dispersion as a marker of torsade de pointes: Disparate effects of class Ia antiarrhythmic drugs and amiodarone. Circulation 1992; 86: 1376-1382.
15. Hohnloser SH. Proarrhythmia with class III antiarrhythmic drugs: Types, risks, and management. Am J Cardiol 1997; 80: 82G-89G.
16. Drouin E, Lande G, Charpentier F. Amiodarone reduces transmural heterogeneity of repolarization in the human heart. J Am Coll Cardiol 1998; 32: 1063-1067.
17. Meierhenrich R, Helguera ME, Kidwell GA, Tebbe U. Influence of amiodarone on QT dispersion in patients with life-threatening ventricular arrhythmias and clinical outcome. Int J Cardiol 1997; 60: 289-294.
18. Grimm W, Steder U, Menz V, Hoffmann J, Maisch B. Effect of amiodarone on QT dispersion in the 12-lead standard electrocardiogram and its significance for subsequent arrhythmic events. Clin Cardiol 1997; 20: 107-110.
19. Antzelevitch C, Shimizu W, Yan GX, Sicouri S. Cellular basis for QT dispersion. J Electrocardiol 1998; 30(Suppl): 168-175.
20. Wang JC, Kiyosue T, Kiriyama K, Arita M. Bepridil differentially inhibits two delayed rectifier K (+) currents. I (Kr) and I (Ks), in guinea-pig ventricular myocytes. Br J Pharmacol 1999; 128: 1733-1738.
21. Liu DW, Antzelevitch C. Characteristics of the delayed rectifier current (IKr and IKs) in canine ventricular epicardial, midmyocardial, and endocardial myocytes: A weaker IKs contributes to the longer action potential of the M cell. Circ Res 1995; 76: 351-365.
22. Namba T, Ashihara T, Nakazawa K, Ohe T. Spatial heterogeneity in refractoriness as a proarrhythmic substrate: Theoretical evaluation by numerical simulation. Jpn Circ J 2000; 64: 121-129.
23. Karle CA, Zitron E, Zhang W, Kathofer S, Schoels W, Kiehn J. Rapid component I (Kr) of the guinea-pig cardiac delayed rectifier K (+) current is inhibited by beta (1)-adrenoreceptor activation, via cAMP/protein kinase A-dependent pathways. Cardiovasc Res 2002; 53: 355-362.
24. Fujiki A, Nishida K, Mizumaki K, Nagasawa H, Shimono M, Inoue H. Spontaneous onset of torsades de pointes in long-QT syndrome and the role of sympathovagal imbalance. Jpn Circ J 2001; 65: 1087-1090.
25. Bonnar CE, Davie AP, Caruana L, Fenn L, Ogston SA, McMurray JJ, et al. QT dispersion in patients with chronic heart failure: Beta blockers are associated with a reduction in QT dispersion. Heart 1999; 81: 297-302.
26. Yi G, Elliott P, McKenna WJ, Prasad K, Sharma S, Guo XH, et al. QT Dispersion and risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy. Am J Cardiol 1998; 82: 1514-1519.
27. Berger F, Borchard U, Hafner D. Effects of the calcium entry blocker bepridil on repolarizing and pacemaker currents in sheep cardiac Purkinje fibres. Naunyn Schmiedebergs Arch Pharmacol 1989; 339: 638-646.